Authors:
Marra, G
D'Atri, S
Corti, C
Bonmassar, L
Cattaruzza, MS
Schweizer, P
Heinimann, K
Bartosova, Z
Nystrom-Lahti, M
Jiricny, J
Citation: G. Marra et al., Tolerance of human MSH2(+/-) lymphoblastoid cells to the methylating agenttemozolomide, P NAS US, 98(13), 2001, pp. 7164-7169
Authors:
Schweizer, P
Moisio, AL
Kuismanen, SA
Truninger, K
Vierumaki, R
Salovaara, R
Arola, J
Butzow, R
Jiricny, J
Peltomaki, P
Nystrom-Lahti, M
Citation: P. Schweizer et al., Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer, CANCER RES, 61(7), 2001, pp. 2813-2815
Authors:
Aktan-Collan, K
Mecklin, JP
Jarvinen, H
Nystrom-Lahti, M
Peltomaki, P
Soderling, I
Uutela, A
de la Chapelle, A
Kaariainen, H
Citation: K. Aktan-collan et al., Predictive genetic testing for hereditary non-polyposis colorectal cancer:Uptake and long-term satisfaction, INT J CANC, 89(1), 2000, pp. 44-50
Authors:
Nystrom-Lahti, M
Holmberg, M
Fidalgo, P
Salovaara, R
de la Chapelle, A
Jiricny, J
Peltomaki, P
Citation: M. Nystrom-lahti et al., Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds, GENE CHROM, 26(4), 1999, pp. 372-375
Authors:
Kuismanen, SA
Holmberg, MT
Salovaara, R
Schweizer, P
Aaltonen, LA
de la Chapelle, A
Nystrom-Lahti, M
Peltomaki, P
Citation: Sa. Kuismanen et al., Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers, P NAS US, 96(22), 1999, pp. 12661-12666